Learn More
Invitrogen™ Human COMMD2 (aa 4-86) Control Fragment Recombinant Protein
Recombinant Protein
Marca: Invitrogen™ RP110234
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-145099 (PA5-145099. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
COMMD2 may modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes. may down-regulate activation of NF-kappa-B.
Especificaciones
Q86X83 | |
Blocking Assay, Control | |
51122 | |
100 μL | |
1190017G07Rik; AI047739; COMM domain containing 2; COMM domain-containing protein 2; COMMD2; D3Ertd176e; HSPC042; My004; wu:fb12e01; zgc:92665 | |
COMMD2 | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human COMMD2 (aa 4-86) Control Fragment | |
RUO | |
COMMD2 | |
Unconjugated | |
Recombinant | |
ELSEEHKEHLAFLPQVDSAVVAEFGRIAVEFLRRGANPKIYEGAARKLNVSSDTVQHGVEGLTYLLTESSKLMISELDFQDSV | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.